Search tool

How can needle exchange services and opioid substitution therapy be safeguarded in the midst of a novel viral outbreak? Scottish Guidance considers potential disruptions to delivery, and suggests ways of ensuring continuity...

The Swiss Addiction Medicine association provides recommendations to doctors and services providing OST during the pandemic to ensure continuity of services.

Press Release: Today, WHO/Europe has published interim guidance on how to deal with the coronavirus disease (COVID-19) in prisons and other places of detention, entitled Preparedness, prevention and control of COVID-19 in...

Updated list of resources related to COVID-19 of particular relavance to people working in the field of harm reduction.

This website documents the French regulation that describes how to adapt OST prescriptions during the pandemic.

This guidance is intended to assist Substance Misuse and homelessness services, and those working with vulnerable populations, especially those with drug and/or alcohol use disorders, co-occurring mental health, and complex needs. This...

Germany. Information on opioid substitution and Sars-CoV-2/Covid-19 - Advice for physicians The coronavirus Sars-CoV-2 has reached the first substitution practices and outpatient clinics in Germany. It is now a matter of a...

This is a joint position paper published by Correlation — the European Harm Reduction Network and the Eurasian Harm Reduction Association, together with the Rights Reporter Foundation on the continuity of harm...